197A — TAUNS Laboratories Income Statement
0.000.00%
Last trade - 00:00- ¥58bn
- ¥63bn
- ¥18bn
- 88
- 57
- 70
- 85
Annual income statement for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho |
| Standards: | JAS | JAS | JAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 17,457 | 15,673 | 18,435 |
| Cost of Revenue | |||
| Gross Profit | 14,682 | 9,200 | 12,498 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 9,502 | 11,005 | 10,411 |
| Operating Profit | 7,955 | 4,668 | 8,024 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 7,976 | 4,655 | 7,835 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 4,481 | 3,035 | 5,774 |
| Net Income Before Extraordinary Items | |||
| Net Income | 4,481 | 3,035 | 5,774 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 4,481 | 3,035 | 5,774 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 63 | 32.3 | 54 |
| Dividends per Share | |||
| Special Dividends per Share |